At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,268 enrolled
Drug / intervention
rizatriptan benzoate +3 moredrug
Likely dose
rizatriptan benzoate 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Placebo-Controlled, Parallel-Groups, Outpatient Study to Examine the Safety, Tolerability, and Efficacy of Single Oral Doses of MK0462 5 mg, MK0462 10 mg, and Sumatriptan 100 mg for Acute Treatment of Migraine
In Brief
A Phase 3 clinical trial evaluating rizatriptan benzoate, Comparator: sumatriptan, and 1 other intervention for Migraine Headache. Completed, enrolled 1,268 participants.
Detailed Summary
A study to compare rizatriptan 10 mg verse sumatriptan 100 mg in the treatment of migraine attacks and duration of relief provided. This study will also provide additional efficacy data on rizatriptan 5 mg and 10 mg for the treatment of migraine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine Headache
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1995
Primary CompletionMay 1996
Study CompletionSep 1996
First PostedMay 2009
TodayJul 2026
First PostedMay 12, 2009
Enrollment StartSep 1, 1995
Primary CompletionMay 1, 1996
Study CompletionSep 1, 1996
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.1 years ago
Interventions
rizatriptan benzoatedrug
single dose administration of 5mg rizatriptan (by Mouth) p.o.
rizatriptan benzoatedrug
single dose administration of 10 mg rizatriptan p.o.
Comparator: sumatriptandrug
single dose administration of sumatriptan 100 p.o.
Comparator: Placebodrug
placebo to rizatriptan